Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jul 15;12:129. doi: 10.1186/s13023-017-0680-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 3 — P1 imaging and functional assessments. P1 fundus picture OU at presentation (a). OCT line OD showed new cystic macular edema, which improved after rituximab infusions (b). Humphrey visual field (HVF) 10–2 OD grey scale and pattern standard deviation showed diffuse peripheral loss while on infliximab (2012, left), which stabilized after a few months on rituximab infusions (2015, right) (c). Western blot analysis after 7 months (top) and 14 months (bottom) on rituximab showed almost complete absence of reaction at follow-up (d)